Koyfin Home > Directory > Health Care > Biogen Inc > EBIT

Biogen Inc EBIT Chart (BIIB)

Biogen Inc annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Biogen Inc EBIT for the quarter ending September 09, 2020 was $1,077m a -59.98% decrease of -646m year over year
  • Biogen Inc EBIT for the last 12 months ending September 09, 2020 was $6,689m a -8.76% decrease of -586m year over year
  • Biogen Inc Annual EBIT for 2019 was $7,275m a 12.52% increase of 911m from 2018
  • Biogen Inc Annual EBIT for 2018 was $6,364m a 7.51% increase of 478m from 2017
  • Biogen Inc Annual EBIT for 2017 was $5,886m a 3.02% increase of 178m from 2016
Other Income Statement Metrics:
  • Biogen Inc EBITDA for the quarter ending December 12, 2018 was $1,738m a -0.80% decrease of -14m year over year
  • Biogen Inc Net Income for the quarter ending December 12, 2018 was $947m a -23.88% decrease of -226m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB EBIT Data

09/2020$1,077m
06/2020$1,999m
03/2020$1,890m
12/2019$1,723m
09/2019$1,947m
06/2019$1,961m
03/2019$1,630m
12/2018$1,699m
09/2018$1,833m
06/2018$1,292m

Annual BIIB EBIT Data

2019$7,275m
2018$6,364m
2017$5,886m
2016$5,709m
2015$5,015m
2014$3,968m
2013$2,490m
2012$1,838m
2011$1,769m
2010$1,576m